- Congressman: McAuliffe victory means gun control a winning message
- Clinton aide admits soliciting disgraced D.C. fundraiser; says actions were legal
- Joel Osteen church victimized in $600K theft
- Obama goes shopping at Gap as minimum-wage thanks
- N.J. woman charged after client dies from black-market butt injections
- CIA chief Brennan ‘determined’ to speak out more this year
- Reset? What reset? U.S.-Russia ties at worst since Cold War
- 9/11 terror recruiter released in Syrian prisoner swap
- D.C. elections board gives green light to marijuana legalization initiative
- Elephants can tell difference between human languages: study
Plan B drug maker: FDA approved pill without restrictions
The drug maker at the heart of a legal fight over access to emergency contraception said Friday it got the green light to offer its one-pill product to customers of all ages, who will not need a prescription or identification to purchase it.
Teva Women's Health of North Wales, Pa., said the Food and Drug Administration approved its request to sell Plan B One-Step without restrictions, after a roller-coaster court battle that had dogged the Obama administration since early April.
"This landmark decision represents the continuation of improving access to emergency contraception to all who need it, when they need it," the company said in a news release.
It is unclear how long it will take for the drug to be freely available on store shelves.
An FDA spokeswoman said Teva will have to ship their newly labeled product to retailers, but referred additional questions to the company.
A company spokeswoman, Denise Bradley, said the pills should be available on shelves by Aug. 1.
The Obama administration initially appealed an April 5 order by U.S. District Judge Edward Korman of New York that made the morning-after pill available without restrictions.
But after an adverse ruling in the appellate court, the Justice Department decided this month to drop its appeal and make the drug as easy to purchase as aspirin.
Conservatives, concerned about the drug's implications for sexual activity among young teens, found themselves aligned with Mr. Obama on the issue, even if their camaraderie was short-lived.
White House spokesman Jay Carney said this month that President Obama still has reservations about selling the drug to young teenage girls.
He said the administration dropped its fight, as a practical matter, after the 2nd U.S. Circuit Court of Appeals ordered it to make a generic, two-pill version of the drug available to all ages while the panel mulled the merits of restricting the one-pill version.
© Copyright 2014 The Washington Times, LLC. Click here for reprint permission.
About the Author
Tom Howell Jr. covers politics for The Washington Times. He can be reached at firstname.lastname@example.org.
- Obamacare enrollment hits 4.2 million, but slowing
- President Obama goes 'Between Two Ferns' to pitch Obamacare
- Obama administration backs off plan to cut prescription-drug program
- Prosecutors: Gray had firsthand knowledge of 'shadow campaign'
- Rate of uninsured Americans is dropping: Gallup
Latest Blog Entries
TWT Video Picks
An America drowning in red ink is the land of the free no more
- David Jolly wins in Florida, GOP keeps swing district seat
- House Democrats trying to force unemployment insurance vote
- Kim Jong-un calls for execution of 33 Christians
- Redskins bypass big splash - for now - as free agency period begins
- U.S. pilot scares off Iranians with 'Top Gun'-worthy stunt: 'You really ought to go home'
- FCC targets black conservative in TV station fight
- Hillary Clinton campaign received funds from Jeffrey Thompson
- Bill Clinton poses for photo with Bunny Ranch prostitutes
- Senate Democrats, Republicans spar over restoring unemployment benefits
- Sharyl Attkisson resigns from CBS after months of talks
Pope Francis meets his 'mini-me'
Celebrity deaths in 2014
Winter storm hits states — again